Literature DB >> 16785230

Peroxisome proliferator-activated receptor gamma-regulated ABCG2 expression confers cytoprotection to human dendritic cells.

Istvan Szatmari1, György Vámosi, Peter Brazda, Balint L Balint, Szilvia Benko, Lajos Széles, Viktoria Jeney, Csilla Ozvegy-Laczka, Attila Szántó, Endre Barta, József Balla, Balazs Sarkadi, Laszlo Nagy.   

Abstract

ABCG2, a member of the ATP-binding cassette transporters has been identified as a protective pump against endogenous and exogenous toxic agents. ABCG2 was shown to be expressed at high levels in stem cells and variably regulated during cell differentiation. Here we demonstrate that functional ABCG2 is expressed in human monocyte-derived dendritic cells by the activation of a nuclear hormone receptor, PPARgamma. We identified and characterized a 150-base pair long conserved enhancer region, containing three functional PPAR response elements (PPARE), upstream of the human ABCG2 gene. We confirmed the binding of the PPARgamma x RXR heterodimer to this enhancer region, suggesting that PPARgamma directly regulates the transcription of ABCG2. Consistent with these results, elevated expression of ABCG2 mRNA was coupled to enhanced protein production, resulting in increased xenobiotic extrusion capacity via ABCG2 in PPARgamma-activated cells. Furthermore PPARgamma instructed dendritic cells showed increased Hoechst dye extrusion and resistance to mitoxantrone. Collectively, these results uncovered a mechanism by which up-regulation of functional ABCG2 expression can be achieved via exogenous or endogenous activation of the lipid-activated transcription factor, PPARgamma. The increased expression of the promiscuous ABCG2 transporter can significantly modify the xenobiotic and drug resistance of human myeloid dendritic cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16785230     DOI: 10.1074/jbc.M604890200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

1.  Glutathione transport is a unique function of the ATP-binding cassette protein ABCG2.

Authors:  Heather M Brechbuhl; Neal Gould; Remy Kachadourian; Wayne R Riekhof; Dennis R Voelker; Brian J Day
Journal:  J Biol Chem       Date:  2010-03-23       Impact factor: 5.157

2.  Virus-induced differential expression of nuclear receptors and coregulators in dendritic cells: implication to interferon production.

Authors:  Sinnie Sin Man Ng; Tsung-Hsien Chang; Prafullakumar Tailor; Keiko Ozato; Tomoshige Kino
Journal:  FEBS Lett       Date:  2011-04-07       Impact factor: 4.124

3.  Transcription factors Sp1 and Sp3 regulate expression of human ABCG2 gene and chemoresistance phenotype.

Authors:  Wook-Jin Yang; Min-Ji Song; Eun Young Park; Jong-Joo Lee; Joo-Hong Park; Keunhee Park; Jong Hoon Park; Hyoung-Pyo Kim
Journal:  Mol Cells       Date:  2013-08-29       Impact factor: 5.034

4.  Targeting the ABCG2-overexpressing multidrug resistant (MDR) cancer cells by PPARγ agonists.

Authors:  Kenneth K W To; Brian Tomlinson
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

Review 5.  The role of transporters in the pharmacokinetics of orally administered drugs.

Authors:  Sarah Shugarts; Leslie Z Benet
Journal:  Pharm Res       Date:  2009-06-30       Impact factor: 4.200

Review 6.  Transcription factor-mediated regulation of the BCRP/ABCG2 efflux transporter: a review across tissues and species.

Authors:  Ludwik Gorczyca; Lauren M Aleksunes
Journal:  Expert Opin Drug Metab Toxicol       Date:  2020-03-14       Impact factor: 4.481

7.  Hepatic and renal Bcrp transporter expression in mice treated with perfluorooctanoic acid.

Authors:  Lobna M Eldasher; Xia Wen; Michael S Little; Kristin M Bircsak; Lindsay L Yacovino; Lauren M Aleksunes
Journal:  Toxicology       Date:  2013-02-19       Impact factor: 4.221

Review 8.  Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance.

Authors:  Karthika Natarajan; Yi Xie; Maria R Baer; Douglas D Ross
Journal:  Biochem Pharmacol       Date:  2012-01-11       Impact factor: 5.858

9.  MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells.

Authors:  Yu-Zhuo Pan; Marilyn E Morris; Ai-Ming Yu
Journal:  Mol Pharmacol       Date:  2009-03-06       Impact factor: 4.436

Review 10.  Redox regulation of multidrug resistance in cancer chemotherapy: molecular mechanisms and therapeutic opportunities.

Authors:  Macus Tien Kuo
Journal:  Antioxid Redox Signal       Date:  2009-01       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.